Biliary Tract Diseases: Clinical Trials

2,245 trials for Biliary Tract Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1035 completed, 419 unknown, 324 recruiting, 145 terminated. 631 Not applicable, 578 Phase 2, 270 Phase 1, 197 Phase 3, 101 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable631Completed 306, Unknown 151, Recruiting 66, Not yet recruiting 37, Terminated 29, Withdrawn 21, Active not recruiting 16, Suspended 3, Enrolling by invitation 2
Phase 2578Completed 226, Recruiting 88, Unknown 80, Terminated 68, Not yet recruiting 45, Active not recruiting 41, Withdrawn 24, Enrolling by invitation 5, Suspended 1
Phase 1270Completed 139, Recruiting 56, Terminated 23, Unknown 22, Active not recruiting 14, Withdrawn 8, Not yet recruiting 7, Suspended 1
Phase 3197Completed 82, Unknown 34, Recruiting 32, Active not recruiting 18, Terminated 14, Withdrawn 8, Not yet recruiting 7, Enrolling by invitation 2
Phase 4101Completed 45, Unknown 32, Terminated 9, Recruiting 8, Not yet recruiting 3, Withdrawn 3, Active not recruiting 1
Early Phase 112Completed 5, Recruiting 4, Unknown 2, Active not recruiting 1

Follow Biliary Tract Diseases: new trials by email Literature Review of Biliary Tract Diseases trials Research Report on Biliary Tract Diseases

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ESP vs Subcostal TAP Block for Analgesia After Laparoscopic Cholecystectomy
Erector Spinae Plane Block, Subcostal Transversus Abdominis Plane Block - Cholelithiasis, Postoperative Pain, Laparoscopic Cholecystectomy
Not applicableNot yet recruitingGaziantep City Hospital1002027-06-152026-06-22
Multicenter Phase 2 Study of Envafolimab in Biliary Tract Cancers
Envafolimab plus Gemcitabine&Cisplatin, Gemcitabine&Cisplatin - Biliary Tract Neoplasms
Phase 2Not yet recruiting3D Medicines (Sichuan) Co., Ltd.1262027-06-012026-03-25
Investigating Precision Medicine in the Adjuvant Setting in Biliary Tract Cancer
Futibatinib, Ivosidenib + Capecitabine, Zanidatamab + Capecitabine - Biliary Tract Cancer (BTC)
Phase 3Not yet recruitingUNICANCER9902027-01-022026-08-04
TRANScriptional Pathways Of Surgical Pain Modulated by Music Therapy Exposure (TRANSPOSE)
Music-assisted relaxation and imagery (MARI) - Surgery, Stomach Cancer
Not applicableNot yet recruitingCase Comprehensive Cancer Center202027-01-012026-08-05
Acute Cholecystitis Biliary Complications - ICG
ICG - Acute Cholecystitis, Biliary Complications
Not applicableNot yet recruitingHospital del Mar2962027-01-012026-03-19
SnapChole: An International, Time-Bound Prospective Platform Study of Management Strategies and Outcomes in Acute Calculous Cholecystitis
Cholecystitis, Acute
Not yet recruitingEuropean Society for Trauma and Emergency Surgery15002027-01-012026-10-01
Zanidatamab Combined With Liposomal Irinotecan and Capecitabine for Second-line Treatment of HER2-positive Unresectable Biliary Tract Tumors
Zanidatamab - Biliary Tract Cancer
Phase 2Not yet recruitingAnhui Provincial Hospital152026-11-302026-10-01
Research on Construction and Verification of Multimodal Medical Imaging Large Model
Liver Diseases, Gallbladder Diseases
Not yet recruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine20002026-11-152026-03-03
Supraglottic Oxygenation Via Oral Transtracheal Catheter for Reducing the Incidence of Hypoxemia During ERCP Under Sedation
The Supraglottic Oxygenation Via Oral Transtracheal Catheter Group, The Regular Nasal Cannula - Choledocholithiasis With Cholecystitis With Obstruction, Obstructive Jaundice
Not applicableNot yet recruitingZhejiang University4102026-11-122026-09-25
Tucatinib Continuation Study
tucatinib - HER2-positive Breast Cancer, Cervical Cancer
Phase 4Not yet recruitingPfizer1752026-11-062026-08-28
Effects of Postoperative Video-assisted Early Mobilization on Recovery Outcomes
Video-Assisted Early Mobilization Training - Cholelithiasis
Not applicableNot yet recruitingMuş Alparslan University442026-11-012026-10-13
Effect of Labetalol, Magnesium Sulfate, or Lidocaine on Opioid Consumption During Laparoscopic Cholecystectomy
Labetalol, Magnesium Sulfate, Lidocaine - Postoperative Pain, Cholelithiasis
Phase 4Not yet recruitingAssiut University902026-11-012026-10-08
Nemolizumab for the Treatment of Moderate to Severe Chronic Hepatic Pruritus
Nemolizumab-ilto - Chronic Hepatic Pruritus, Cholestatic Liver Disease
Phase 2Not yet recruitingMayo Clinic152026-11-012026-09-28
Phase 2 Study of Daraxonrasib in Recurrent KRAS-Mutant Biliary Tract Cancer
Daraxonrasib - Biliary Tract Cancers, Intrahepatic Cholangiocarcinoma (Icc)
Phase 2Not yet recruitingSidney Kimmel Comprehensive Cancer Center at Johns Hopkins552026-11-012026-08-28
Alternating Chemo-immunotherapy and FGFR Inhibitor for FGFR-positive Biliary or Cholangiocarcinoma
Biospecimen Collection, Cisplatin, Computed Tomography - Locally Advanced Ampulla of Vater Carcinoma, Locally Advanced Biliary Tract Carcinoma
Phase 2RecruitingOhio State University Comprehensive Cancer Center292026-11-012026-09-10
IKS04 Regimen in Advanced Solid Tumors That Express CA242
IKS04 antibody drug conjugate ADC + Isumab04 monoclonal antibody - Colorectal Cancer, Gastro Esophageal Junctional Cancer
Phase 1Not yet recruitingIksuda Therapeutics Ltd.1202026-11-012026-07-31
Electrosurgical Patterns and Learning Curve in Elective Laparoscopic Cholecystectomy
Elective laparoscopic cholecystectomy - Cholelithiasis
RecruitingUniversity Hospital of Split1652026-10-152026-10-22
J-LINX: Japan LINerixibat eXtension Study
Linerixibat - Pruritus
Phase 3Not yet recruitingGlaxoSmithKline402026-10-092026-10-06
Two Bupivacaine Concentrations for Rectus Intercostal Fascial Plane Block After Laparoscopic Cholecystectomy
Bupivacaine 0.25% - rectus intercostal fascial plane block, Bupivacaine 0.125% - rectus intercostal fascial plane block, Bupivacaine 0.25% - port-site infiltration - Postoperative Pain, Acute Pain
Not applicableNot yet recruitingMedipol University902026-10-052026-10-05
SumMET: Study of [225Ac]Ac-FL-261 in Participants With Solid Tumors Overexpressing c-MET
[225Ac]Ac-FL-261 - Solid Tumor, NSCLC
Phase 1 / Phase 2RecruitingFull-Life Technologies UK Limited2082026-10-012026-10-16

Showing 20 of 2245. Sign in to see all of them.

Narrower conditions

Biliary Tract Neoplasms (479)  ·  Gallbladder Neoplasms (295)  ·  Bile Duct Neoplasms (251)  ·  Pancreatic Neoplasms (246)  ·  Cholangiocarcinoma (238)  ·  Liver Cirrhosis, Biliary (212)  ·  Gallstones (188)  ·  Cholelithiasis (181)  ·  Cholecystitis (175)  ·  Stomach Neoplasms (152)  ·  Cholangitis, Sclerosing (146)  ·  Cholecystitis, Acute (138)  ·  Cholestasis (138)  ·  Carcinoma, Hepatocellular (109)  ·  Choledocholithiasis (107)

Broader conditions

Digestive System Diseases (2219)  ·  Bile Duct Diseases (991)  ·  Neoplasms by Site (896)  ·  Digestive System Neoplasms (885)  ·  Neoplasms (869)  ·  Gallbladder Diseases (748)  ·  Pathological Conditions, Signs and Symptoms (725)  ·  Pathologic Processes (470)  ·  Liver Diseases (437)  ·  Neoplasms by Histologic Type (408)  ·  Neoplasms, Glandular and Epithelial (386)  ·  Biliary Tract Neoplasms (369)  ·  Carcinoma (362)  ·  Adenocarcinoma (342)

Interventions

Gemcitabine (165)  ·  Cisplatin (112)  ·  Cholecystectomy, Laparoscopic (77)  ·  Capecitabine (68)  ·  Oxaliplatin (61)  ·  Fluorouracil (50)  ·  Cholangiopancreatography, Endoscopic Retrograde (45)  ·  Ursodeoxycholic Acid (43)  ·  Leucovorin (40)  ·  durvalumab (39)  ·  pembrolizumab (39)  ·  Cholecystectomy (33)  ·  Irinotecan (26)  ·  fish oil triglycerides (23)  ·  130-nm albumin-bound paclitaxel (22)

Sponsors

National Cancer Institute (NCI) (40)  ·  Mayo Clinic (30)  ·  Mirum Pharmaceuticals, Inc. (24)  ·  Assiut University (22)  ·  Peking Union Medical College Hospital (22)  ·  Seoul National University Hospital (20)  ·  AstraZeneca (19)  ·  Gilead Sciences (17)  ·  Karolinska Institutet (15)  ·  Hepatopancreatobiliary Surgery Institute of Gansu Province (14)  ·  Intercept Pharmaceuticals (14)  ·  Xijing Hospital of Digestive Diseases (14)  ·  Yonsei University (14)  ·  RenJi Hospital (13)  ·  Stanford University (13)

Countries

United States (673)  ·  China (406)  ·  South Korea (197)  ·  United Kingdom (156)  ·  France (143)  ·  Italy (140)  ·  Germany (138)  ·  Spain (136)  ·  Canada (131)  ·  Turkey (Türkiye) (94)  ·  Japan (83)  ·  Australia (77)  ·  Belgium (74)  ·  Taiwan (66)  ·  Egypt (65)

Top investigators

Michel Kahaleh, MD (9)  ·  Ed Doo, MD (8)  ·  Lisa Henn, PhD (6)  ·  John Magee, MD (5)  ·  Katrina Loh, MD (5)  ·  Li Yang, MD (5)  ·  Tim F Greten, M.D. (5)  ·  Hiroaki Nagano, MD, PhD (4)

Results publications

PMID 20375404, PMID 21910897, PMID 25543678, PMID 37121331, PMID 33198671, PMID 37069476, PMID 38661512, PMID 38780109, PMID 42002216, PMID 17509029, PMID 17704863, PMID 1858735, PMID 19286178, PMID 19376789, PMID 19670912, PMID 20211892, PMID 2070995, PMID 22872303, PMID 23054338, PMID 23612857, PMID 24022431, PMID 24146220, PMID 24867013, PMID 25005650, PMID 25477010, PMID 26179201, PMID 26186803, PMID 26561627, PMID 26725209, PMID 27546389, PMID 27741006, PMID 28249726, PMID 28818953, PMID 28941329, PMID 29433850, PMID 29519540, PMID 29533266, PMID 29610513, PMID 29847616, PMID 29954008, PMID 29961772, PMID 30420614, PMID 30642373, PMID 30979521, PMID 30998813, PMID 31863440, PMID 32059815, PMID 32461347, PMID 32633158, PMID 32707155

NIH funding

2023 (21), 2016 (11), 2015 (10), 2019 (9), U01DK062456 (7), 2014 (6), 2025 (6), 2017 (5), 2018 (5), P30CA015083 (5), U01DK062436 (5), U01DK062445 (5), U01DK062452 (5), U01DK062453 (5), U01DK062466 (5)